Skip to main content
. 2026 Mar 13;62(3):532. doi: 10.3390/medicina62030532
AF atrial fibrillation
AKI acute kidney injury 
BMI body mass index
CAD coronary artery disease
CKD chronic kidney disease
CKD-EPI Chronic Kidney Disease Epidemiology Collaboration
eGFR estimated glomerular filtration rate
ESRD end-stage renal disease
HbA1c hemoglobin A1c
INR international normalized ratio
LDL low-density lipoprotein
LVEF left ventricular ejection fraction
NOACs non-vitamin K antagonist oral anticoagulants
NSAIDs nonsteroidal anti-inflammatory drugs
NVAF nonvalvular atrial fibrillation
PAR protease-activated receptor
RAAS inhibitors renin–angiotensin–aldosterone system inhibitors
SBP systolic blood pressure
SCr serum creatinine
SEE systemic embolism event
SGLT-2 inhibitors sodium-glucose cotransporter-2 inhibitors
TTR time in therapeutic range
VKAs vitamin K antagonists
WRN warfarin-related nephropathy